-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UdpCAF/Qlw8JBpcpATbWUwmaoOkNoPw9c/LdRNyqX5jNTaEg6lpJ7xflZpN1mibd Y4h1LiNJpgfeEGZowcVW5g== /in/edgar/work/0001009448-00-000115/0001009448-00-000115.txt : 20001116 0001009448-00-000115.hdr.sgml : 20001116 ACCESSION NUMBER: 0001009448-00-000115 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20000930 FILED AS OF DATE: 20001115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BCAM INTERNATIONAL INC CENTRAL INDEX KEY: 0000856143 STANDARD INDUSTRIAL CLASSIFICATION: [2835 ] IRS NUMBER: 133228375 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: SEC FILE NUMBER: 001-10420 FILM NUMBER: 769699 BUSINESS ADDRESS: STREET 1: 1800 WALT WHITMAN RD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 5167523550 MAIL ADDRESS: STREET 1: 1800 WALT WHITMAN RD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: BIOMECHANICS CORP OF AMERICA DATE OF NAME CHANGE: 19920703 NT 10-Q 1 0001.txt NOTIFICATION OF LATE FILING OF 10Q OMB APPROVAL OMB NUMBER 3235-0058 EXPIRES: MAY 31, 1997 Estimated average burden hour per response...2.50 SEC FILE NUMBER 1-7948 CUSIP NUMBER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): __ Form 10-K __ Form 20-F __ Form 11-K X Form 10Q __ Form N-SAR For Period Ended: September 30, 2000 [ ] Transition Report on Form 10-K [ ]Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended:_________________________________________ Read Instruction (on back page) Before Preparing Form. Please Print or Type. ---------------------------------------------------------------------------- Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. If the notification relates to a portion of the filing check above, identify the Item(s) to which the notification relates: PART I -- REGISTRANT INFORMATION CELLMETRIX, INC. Full Name of Registrant BCAM INTERNATIONAL, INC. Former Name if Applicable 1800 Walt Whitman Road Address of Principal Executive Office (Street and Number) Melville, NY 11747 City, State and Zip Code PART II -- RULES 12b-25(b) and (c) If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate). (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. PART III - NARRATIVE State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period. The Company currently does not have a Chief Financial Officer which has delayed the completion of its financial statements. Because of this vacancy, management needs an additional period of five days from the date hereof to finalize the financial statements and file Form 10-QSB for the quarter ended September 30, 2000. PART IV - OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Michael Recca (914) 712-0620 ------------- ----- -------- (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is not, identify report(s), X Yes __No --------------------------------------------------------------------------- (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? X Yes __No If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. (See attached Exhibit IV-3) BCAM INTERNATIONAL, INC. (Name of Registrant as Specified in Charter) has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 14, 2000 By: /s/ ------------------------------- Michael Recca, Chairman of the Board of Directors EX-99 2 0002.txt EXHIBIT IV-3 Exhibit IV-3 It is anticipated that a significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the financial statements that will be included in the Company's 10-QSB for the fiscal quarter ended September 30, 2000. Such additional change is due to the recent resignations of the President and Chief Executive Officer and all of the Board of Directors of the Company as reported in the Form 8-K filed October 26, 2000, which has prohibited the Company from producing a narrative or quantitative estimate of the anticipated change. The Company does, however, anticipate to report insignificant revenues for the fiscal quarter ended September 30, 2000. -----END PRIVACY-ENHANCED MESSAGE-----